Fri, 23 Feb 2024 14:44:37 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2024/01/cropped-CTA-ONA-HEM-favicon-32x32.png 32 32 https://www.oncologynurseadvisor.com/home/cancer-types/brain-cancer/brain-cancer-risk-increased-after-moderate-severe-penetrating-tbi/ Fri, 23 Feb 2024 14:00:00 +0000 https://www.oncologynurseadvisor.com/?p=116789 https://www.oncologynurseadvisor.com/home/cancer-types/brain-cancer/bevacizumab-pediatric-rel-ref-high-risk-neuroblastoma/ Fri, 26 Jan 2024 15:30:00 +0000 https://www.oncologynurseadvisor.com/?p=116154 https://www.oncologynurseadvisor.com/home/cancer-types/brain-cancer/dabrafenib-trametinib-active-in-pediatric-glioma-with-braf-v600/ Mon, 25 Sep 2023 14:00:00 +0000 https://www.oncologynurseadvisor.com/?p=110835 More responses, longer progression-free survival seen compared with standard chemo for low-grade glioma with BRAF V600 mutations.]]> https://www.oncologynurseadvisor.com/home/cancer-types/brain-cancer/asco-vorasidenib-improves-progression-free-survival-in-grade-2-idh-mutant-glioma/ Wed, 14 Jun 2023 14:00:00 +0000 https://www.oncologynurseadvisor.com/?p=108256 Significant improvement seen in progression-free survival and in time to next intervention for vorasidenib versus placebo.]]> https://www.oncologynurseadvisor.com/home/cancer-types/brain-cancer/brain-tumor-communication-distress-levels-neuro-oncology-patients-link/ Mon, 12 Jun 2023 15:00:00 +0000 https://www.oncologynurseadvisor.com/?p=108502 A pilot study investigated the association between distress levels and communication needs in patients with glioma.]]> https://www.oncologynurseadvisor.com/home/cancer-types/brain-cancer/vorasidenib-idh1-2-mutated-glioma-new-standard-care/ Wed, 07 Jun 2023 14:30:00 +0000 https://www.oncologynurseadvisor.com/?p=108183 If approved, vorasidenib could become a new standard of care for low-grade IDH1/2-mutated gliomas, according to an ASCO discussant.]]> https://www.oncologynurseadvisor.com/home/cancer-types/brain-cancer/ultrasound-glioblastoma-technique-delivers-paclitaxel-blood-brain-barrier/ Tue, 23 May 2023 14:40:00 +0000 https://www.oncologynurseadvisor.com/?p=107755 An ultrasound technique allows for delivery of albumin-bound paclitaxel across the blood-brain barrier in patients with recurrent glioblastoma, a study suggests. ]]> https://www.oncologynurseadvisor.com/home/cancer-types/brain-cancer/car-t-cells-targeting-gd2-feasible-safe-for-pediatric-neuroblastoma/ Mon, 17 Apr 2023 13:30:00 +0000 https://www.oncologynurseadvisor.com/?p=106463 GD2-targeted CAR T cells expanded in vivo, and were detectable in peripheral blood up to 30 months after infusion.]]> https://www.oncologynurseadvisor.com/home/cancer-types/brain-cancer/transplant-from-deceased-donor-with-brain-tumor-appears-to-be-safe/ Tue, 04 Apr 2023 14:20:00 +0000 https://www.oncologynurseadvisor.com/?p=106153 Risk for cancer transmission lower than thought, and long-term transplant outcomes favorable.]]> https://www.oncologynurseadvisor.com/home/cancer-types/brain-cancer/interferon-alfa-high-grade-glioma-improves-standard-care/ Thu, 02 Feb 2023 15:40:00 +0000 https://www.oncologynurseadvisor.com/?p=104742 Adding interferon alfa to treatment with temozolomide and radiotherapy prolongs survival in patients with newly diagnosed, high grade glioma, a phase 3 trial suggests.]]>